EC Healthcare Maintains Stable Share Base in March 2026; Slight Decline in Outstanding Options

Bulletin Express04-01

For the month ended 31 March 2026, EC Healthcare reported no changes in either authorised or issued share capital. Authorised share capital remained at HKD 380,000, representing 38 billion ordinary shares with a par value of HKD 0.00001 each.

Issued shares (excluding treasury shares) were unchanged at 1.19 billion, and the company confirmed compliance with the Main Board’s minimum 25 % public-float requirement. No treasury shares were held or transacted during the period.

Share-option activity was limited to the lapse of 40,000 options under the 2016 Share Option Scheme, reducing outstanding options under that plan to 18.92 million. The newer scheme approved in May 2023 maintained 59.26 million outstanding options, with no new grants, exercises, or cancellations.

No warrants, convertible securities, other share-issuance arrangements, or Hong Kong Depositary Receipts were reported. Total funds raised from option exercises during the month were HKD 0.

Overall, EC Healthcare’s capital structure and liquidity indicators remained stable throughout March 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1101885733?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-01 17:47","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1101885733","market":"us","top_or_hot":-1,"title":"EC Healthcare Maintains Stable Share Base in March 2026; Slight Decline in Outstanding Options","media":"Bulletin Express","content":"<p>For the month ended 31 March 2026, EC Healthcare reported no changes in either authorised or issued share capital. Authorised share capital remained at HKD 380,000, representing 38 billion ordinary shares with a par value of HKD 0.00001 each.</p>\n<p>Issued shares (excluding treasury shares) were unchanged at 1.19 billion, and the company confirmed compliance with the Main Board’s minimum 25 % public-float requirement. No treasury shares were held or transacted during the period.</p>\n<p>Share-option activity was limited to the lapse of 40,000 options under the 2016 Share Option Scheme, reducing outstanding options under that plan to 18.92 million. The newer scheme approved in May 2023 maintained 59.26 million outstanding options, with no new grants, exercises, or cancellations.</p>\n<p>No warrants, convertible securities, other share-issuance arrangements, or Hong Kong Depositary Receipts were reported. Total funds raised from option exercises during the month were HKD 0.</p>\n<p>Overall, EC Healthcare’s capital structure and liquidity indicators remained stable throughout March 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>EC Healthcare Maintains Stable Share Base in March 2026; Slight Decline in Outstanding Options</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEC Healthcare Maintains Stable Share Base in March 2026; Slight Decline in Outstanding Options\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-04-01 17:47</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>For the month ended 31 March 2026, EC Healthcare reported no changes in either authorised or issued share capital. Authorised share capital remained at HKD 380,000, representing 38 billion ordinary shares with a par value of HKD 0.00001 each.</p>\n<p>Issued shares (excluding treasury shares) were unchanged at 1.19 billion, and the company confirmed compliance with the Main Board’s minimum 25 % public-float requirement. No treasury shares were held or transacted during the period.</p>\n<p>Share-option activity was limited to the lapse of 40,000 options under the 2016 Share Option Scheme, reducing outstanding options under that plan to 18.92 million. The newer scheme approved in May 2023 maintained 59.26 million outstanding options, with no new grants, exercises, or cancellations.</p>\n<p>No warrants, convertible securities, other share-issuance arrangements, or Hong Kong Depositary Receipts were reported. Total funds raised from option exercises during the month were HKD 0.</p>\n<p>Overall, EC Healthcare’s capital structure and liquidity indicators remained stable throughout March 2026.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02138","symbol_name":"医思健康","start_time":0,"source_url":"","article_id":"1101885733","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1101885733","pubTimestamp":1775036850,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"For the month ended 31 March 2026, EC Healthcare reported no changes in either authorised or issued share capital. Authorised share capital remained at HKD 380,000, representing 38 billion ordinary...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02138":"医思健康"},"translate_title":"EC Healthcare在2026年3月保持稳定的份额基础；未偿期权略有下降","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02138":1},"content_text":"For the month ended 31 March 2026, EC Healthcare reported no changes in either authorised or issued share capital. Authorised share capital remained at HKD 380,000, representing 38 billion ordinary shares with a par value of HKD 0.00001 each.\nIssued shares (excluding treasury shares) were unchanged at 1.19 billion, and the company confirmed compliance with the Main Board’s minimum 25 % public-float requirement. No treasury shares were held or transacted during the period.\nShare-option activity was limited to the lapse of 40,000 options under the 2016 Share Option Scheme, reducing outstanding options under that plan to 18.92 million. The newer scheme approved in May 2023 maintained 59.26 million outstanding options, with no new grants, exercises, or cancellations.\nNo warrants, convertible securities, other share-issuance arrangements, or Hong Kong Depositary Receipts were reported. Total funds raised from option exercises during the month were HKD 0.\nOverall, EC Healthcare’s capital structure and liquidity indicators remained stable throughout March 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1101885733","isCrawlerRequest":true}